Cim, LLC Ligand Pharmaceuticals Inc Transaction History

Cim, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$128.36 - $272.13 $130,670 - $277,028	-1,018 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$211.18 - $274.49 $4,645 - $6,038	-22 Reduced 2.12%	1,018 $279,000
Q2 2018 Jul 10, 2018	BUY	$150.77 - $207.98 $156,800 - $216,299	1,040 New	1,040 $215,000

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.85B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.